Variable phenotypes are associated with PMP22 missense mutations

Charcot-Marie-Tooth disease (CMT) is the commonest hereditary neuropathy encompassing a large group of clinically and genetically heterogeneous disorders. The commonest form of CMT, CMT1A, is usually caused by a 1.4 megabase duplication of chromosome 17 containing the PMP22 gene. Mutations of PMP22 are a less common cause of CMT. We describe clinical, electrophysiological and molecular findings of 10 patients carrying PMP22 missense mutations. The phenotype varied from mild hereditary neuropathy with liability to pressure palsies (HNPP) to severe CMT1. We identified six different point mutations, including two novel mutations. Three families were also found to harbour a Thr118Met mutation. Although PMP22 point mutations are not common, our findings highlight the importance of sequencing the PMP22 gene in patients with variable CMT phenotypes and also confirm that the PMP22 Thr118Met mutation is associated with a neuropathy albeit with reduced penetrance.

[1]  S. Greenberg,et al.  Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene. , 1996, Journal of medical genetics.

[2]  N. Wood,et al.  Dejerine‐sottas neuropathy and PMP22 point mutations: A new base pair substitution and a possible “hot spot” on Ser72 , 1998, Annals of neurology.

[3]  W. Löscher,et al.  Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations , 2009, European Journal of Human Genetics.

[4]  U. Suter,et al.  Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral Neuropathies , 1999, Neurobiology of Disease.

[5]  E. Jabs,et al.  A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. , 1999, American journal of human genetics.

[6]  G. Holmgren,et al.  PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism? , 1997, Nature Genetics.

[7]  Byung-Ok Choi,et al.  Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot‐Marie‐Tooth neuropathy patients , 2004, Human mutation.

[8]  J. Lupski,et al.  Dejerine–Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene , 1993, Nature Genetics.

[9]  C. Disteche,et al.  DNA deletion associated with hereditary neuropathy with liability to pressure palsies , 1993, Cell.

[10]  G. Siciliano,et al.  Charcot‐Marie‐Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families , 2001, Human mutation.

[11]  P. Patel,et al.  Mutation analysis of the nerve specific promoter of the peripheral myelin protein 22 gene in CMT1 disease and HNPP. , 1998, Journal of medical genetics.

[12]  M. Reilly.  Sorting out the inherited neuropathies. , 2007, Practical neurology.

[13]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[14]  I. Akiguchi,et al.  Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot‐Marie‐Tooth disease type 1 , 2000, Annals of neurology.

[15]  H. Houlden,et al.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease , 2007, NeuroMolecular Medicine.

[16]  X. Estivill,et al.  Variants of STAT6 (signal transducer and activator of transcription 6) in atopic asthma , 2000, Journal of medical genetics.

[17]  F. Baas,et al.  Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) , 1991, Neuromuscular Disorders.

[18]  J. Lupski,et al.  T118M PMP22 mutation causes partial loss of function and HNPP‐like neuropathy , 2006, Annals of neurology.

[19]  J. Lupski,et al.  Charcot‐Marie‐Tooth disease and related neuropathies: Mutation distribution and genotype‐phenotype correlation , 2002, Annals of neurology.

[20]  U. Suter,et al.  Many facets of the peripheral myelin protein PMP22 in myelination and disease , 1998, Microscopy research and technique.

[21]  F. Muntoni,et al.  Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. , 1997, Brain : a journal of neurology.

[22]  A. Simonati,et al.  Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point mutation of peripheral myelin protein-22 , 1999, Neurology.

[23]  C. van Broeckhoven,et al.  PMP22 Thr118Met is not a clinically relevant CMT1 marker , 2000, Journal of Neurology.

[24]  Y. Parman,et al.  Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine‐Sottas disease , 1999, Annals of neurology.

[25]  M. Shy,et al.  Diagnosis and new treatments in genetic neuropathies , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  K. Kleopa,et al.  A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes , 2004, Neurogenetics.

[27]  Jun Yu Li,et al.  Reliability and validity of the CMT neuropathy score as a measure of disability , 2005, Neurology.

[28]  M. Mostacciuolo,et al.  PMP22 related congenital hypomyelination neuropathy , 2001, Journal of neurology, neurosurgery, and psychiatry.